SOPHiA GENETICS SA·4

Apr 16, 4:03 PM ET

Muken Ross 4

4 · SOPHiA GENETICS SA · Filed Apr 16, 2026

Research Summary

AI-generated summary of this filing

Updated

SOPHiA GENETICS (SOPH) President Muken Ross Sells 2,800 Shares

What Happened

  • Muken Ross, President of SOPHiA GENETICS SA, sold 2,800 ordinary shares in an open-market transaction on April 14, 2026. The weighted-average sale price was $4.96 per share for a total proceeds of $13,887.
  • This was a sale (S) executed to satisfy tax withholding related to restricted stock units that vested earlier in April; such sales are often routine and do not necessarily signal a change in view on the company.

Key Details

  • Transaction date: 2026-04-14; Form 4 filed 2026-04-16 (timely within required window).
  • Quantity and price: 2,800 shares sold at a weighted average price of $4.96; sale prices ranged between $4.75 and $5.16 (weighted avg reported).
  • Total proceeds reported: $13,887.
  • Footnotes: F1 — shares sold to satisfy tax withholding from RSU vesting on April 2 and 3, 2026; F1 also notes the trades were effected under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary. F2 — issuer/staff may request breakdown of number of shares sold at each separate price within the stated range.
  • Shares owned after the transaction: not specified in the provided filing excerpt.

Context

  • Sales made solely to cover tax withholding on vested awards are common and treated as administrative transactions (often coded F for tax withholding in reporting). They provide less insight into the insider’s view than open-market purchases.
  • For retail investors, purchases by insiders tend to be more informative than routine sales like this one.

Insider Transaction Report

Form 4
Period: 2026-04-14
Muken Ross
DirectorChief Executive Officer
Transactions
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-04-14$4.96/sh2,800$13,887682,432 total
Footnotes (2)
  • [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.75 to $5.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Ross Muken|2026-04-16

Documents

1 file
  • 4
    wk-form4_1776369800.xmlPrimary

    FORM 4